Literature DB >> 18091046

Novel low-cost assay for the monitoring of CD4 counts in HIV-infected individuals.

Kriengkrai Srithanaviboonchai1, Kittipong Rungruengthanakit, Phonethipsavanh Nouanthong, Supansa Pata, Thira Sirisanthana, Watchara Kasinrerk.   

Abstract

Several CD4 lymphocyte enumeration methods have been developed to be used as alternatives to conventional flow cytometry. However, no consensus has been reached on which technique should be widely adopted. We introduce here a novel nonflow cytometric method, called CD4 Select, for enumeration of CD4 lymphocytes. Instead of using a flow cytometer, the method requires only an automatic hematoanalyzer (complete blood count [CBC] machine). The correlations of the percentage of CD4 lymphocytes and absolute CD4 counts with the CD4 Select method and standard flow cytometry were 0.932 and 0.922, respectively. The CD4 Select method yielded percentage of CD4 lymphocytes greater than flow cytometry by a mean of 0.06%, and the limits of agreement at 95% confidence interval (CI) were 9.46% to -9.56% using Bland-Altman analysis. The CD4 select method is cheap, valid, and simple enough to be conducted locally at small facilities. The method yields not only absolute CD4 lymphocytes, but also percentage of CD4 lymphocytes. The use of a hematoanalyzer also gives this method relatively high sample throughput and makes it less labor-intensive than other nonflow cytometric methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18091046     DOI: 10.1097/QAI.0b013e3181624ab5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

1.  Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patients.

Authors:  Farzad Noubary; Michael D Hughes
Journal:  Stat Med       Date:  2010-08-15       Impact factor: 2.373

2.  Microfluidic differential immunocapture biochip for specific leukocyte counting.

Authors:  Umer Hassan; Nicholas N Watkins; Bobby Reddy; Gregory Damhorst; Rashid Bashir
Journal:  Nat Protoc       Date:  2016-03-10       Impact factor: 13.491

Review 3.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.